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SSRP1-mediated histone H1 eviction promotes
replication origin assembly and accelerated
development
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In several metazoans, the number of active replication origins in embryonic nuclei is higher
than in somatic ones, ensuring rapid genome duplication during synchronous embryonic cell
divisions. High replication origin density can be restored by somatic nuclear reprogramming.
However, mechanisms underlying high replication origin density formation coupled to rapid
cell cycles are poorly understood. Here, using Xenopus laevis, we show that SSRP1 stimulates
replication origin assembly on somatic chromatin by promoting eviction of histone H1
through its N-terminal domain. Histone H1 removal derepresses ORC and MCM chromatin
binding, allowing efficient replication origin assembly. SSRP1 protein decays at mid-blastula
transition (MBT) when asynchronous somatic cell cycles start. Increasing levels of SSRP1
delay MBT and, surprisingly, accelerate post-MBT cell cycle speed and embryo development.
These findings identify a major epigenetic mechanism regulating DNA replication and
directly linking replication origin assembly, cell cycle duration and embryo development in
vertebrates.
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Eukaryotic replication origins are assembled by the orderlyrecruitment of protein factors to initiation sites. The originrecognition complex (ORC) binds to replication origins
and, together with Cdt1 and Cdc6, promotes the pre-replication
complex (pre-RC) assembly by orchestrating the loading of the
MCM helicase complex. The MCM complex remains inactive until
Dbf4-dependent kinase (DDK) and cyclin-dependent kinases
(CDKs) trigger the recruitment of initiation factors Cdc45 and GINS
forming the CMG complex, which together with DNA polymerases
duplicates the DNA1. Factors such as chromatin configuration,
DNA sequence and shape and other proteins including histone
acetylation enzymes, chromatin remodelers and histone chaperones
affect pre-RC assembly. However, their precise roles are poorly
understood2.
In Xenopus laevis early embryos and egg extracts DNA repli-
cation starts from replication origins separated by an average
inter-origin distance of 9–12 kb (refs. 3,4). This replication origin
density persists for the first 12 synchronous cell cycles, up to the
MBT, when cell division becomes asynchronous, transcription is
activated and slower and asynchronous somatic cell cycles start5.
Somatic cells, instead, replicate DNA from fewer replication
origins. Highly differentiated cells such erythrocytes assemble
origins at an average inter-origin distance of 100–120 kb (ref. 6).
Titration of replication initiation factors Cdc45, Drf1, TopBP1,
and Treslin has been in part linked to the lower replication origin
density at MBT7. However, embryonic replication density is not
restored when somatic nuclei are incubated in interphase egg
extracts despite the excess of replication initiation factors6, indi-
cating the existence of additional mechanisms that prevent
replication origin assembly on somatic nuclei. Chromatin con-
figuration could contribute to the decreased number of origins on
post-MBT somatic nuclei by suppressing the chromatin binding
of replication origin components. Consistent with this, decreased
replication origin density correlates with decreased levels of ORC
complex loaded onto somatic DNA, indicating that chromatin-
bound factors upstream ORC may regulate DNA ORC binding
and distribution6.
Intriguingly, embryonic replication origin density can be
restored on somatic nuclei by incubation in intact unfertilized
eggs or their mitotic arrested extracts6,8,9. This process is
accompanied by active chromatin remodeling and removal of
somatic chromatin-bound proteins such as transcription factors.
Replication origin re-configuration is thought to be essential for
nuclear reprogramming obtained through somatic cell nuclear
transfer6,9,10.
Somatic nuclei contain high amounts of histone H1, which
contribute to chromatin compaction11 and could restrain
replication origin assembly. Here, we show that SSRP1, through
its N-Terminal region, promotes histone H1 removal from
somatic chromatin, licensing replication origins assembly on
somatic nuclei in egg extracts. SSRP1 together with SPT16 forms
the FACT complex, a major chromatin remodeller12–14. Criti-
cally, we show that SSRP1 protein levels, decrease at MBT when
somatic DNA replication and asynchronous cell cycles start.
SSRP1 overexpression can significantly delay the onset of MBT
and somatic cycles. Strikingly, SSRP1 sets the speed of post-
MBT development as embryos exposed to higher SSRP1 protein
levels develop at a significant faster pace. This is likely due to
enhanced replication origin assembly, which increases the speed
of genome duplication and cell cycle. These findings indicate
that chromatin configuration and replication origin assembly
are directly linked to the control of somatic cell cycle duration in
vertebrate development. Considering that high levels of SSRP1
and the FACT complex have been shown to drive tumor
growth15 and that recent work highlighted a key role for the
linker histone H1.0 in suppressing cancer cell proliferation and
self-renewal16,17 our results set the stage to better understand
this central epigenetic regulation in DNA metabolism and
cell cycle.
Results
Isolation of SSRP1 as somatic nuclei replication activator.
Somatic nuclei (~4000 nuclei/μl) derived from Xenopus ery-
throcytes do not replicate efficiently in interphase egg extract in
which replication factors are not limiting. However, prolonged
pre-incubation of somatic nuclei in cytostatic factor arrested
(CSF) mitotic extract derived from unfertilized eggs allows their
efficient replication in interphase extract6 (Fig. 1a). Collectively,
these observations suggest that inhibitory factors on somatic
chromatin prevent DNA replication and that these are removed
in unfertilized mitotic eggs and extracts. Unexpectedly, by
titrating somatic nuclei we found that a low number of nuclei
could also be efficiently replicated in interphase egg extract
similar to sperm nuclei, the number of which did not significantly
affect replication efficiency18 (Fig. 1b). These observations indi-
cated that interphase extracts contain factors present in limiting
amounts able to remove inhibitory constraints preventing effi-
cient somatic nuclei replication. To identify these factors, we
fractionated and concentrated interphase egg extract using
polyethylene glycol (PEG). Fractions precipitated with increasing
concentrations of PEG were pre-incubated with somatic nuclei,
which were then transferred to interphase egg extracts (Fig. 1c, d)
to assay their ability to stimulate DNA replication. The fraction
with the highest activity was recovered from the 9% PEG pellet,
which contained several proteins (Supplementary Fig. 1a). To
identify the factor responsible for this effect the active fraction
was separated by column chromatography to isolate DNA
binding proteins able to stimulate somatic nuclei replication
(Fig 1e). The active PEG and column fractions were analysed by
gel free multi-dimensional protein identification tandem mass
spectrometry (MS)19. We found a high number of SSRP1 peptides
together with lower amount of SPT16 peptides in the fraction
with the highest stimulatory specific activity (Supplementary
Data 1). As somatic chromatin configuration was possibly
responsible for the inhibition of somatic nuclei replication we
tested the ability of SSRP1 and SPT16 to stimulate somatic DNA
replication. To this end we produced recombinant human Flag-
SSRP1 and 6xHis-SPT16 proteins, which are highly similar to the
Xenopus orthologs and could be easily expressed in soluble form
(Supplementary Fig. 1b). We found that recombinant SSRP1
alone and in complex with SPT16 pre-incubated with somatic
nuclei was able to stimulate their replication in interphase extract
without prior incubation in CSF-arrested mitotic egg extracts
(Fig. 2a, b). The stimulatory effect was linearly correlated to the
amount of SSRP1 protein and was already detectable at 50 ng/μl,
corresponding to 545 nM, 2.8-fold higher than endogenous
SSRP1 concentration, which was estimated to be ~190 nM
(ref. 20). Noticeably, SPT16 alone did not stimulate DNA repli-
cation, suggesting that SSRP1 was sufficient to produce this effect
(Fig. 2a).
To test whether SSRP1 was acting on the general DNA
replication machinery we incubated SSRP1 with sperm nuclei. In
this case SSRP1 was unable to stimulate DNA replication when
sperm nuclei were used as template, indicating that SSRP1 was
only able to promote replication of somatic nuclei (Fig. 2c),
excluding that SSRP1 was directly affecting the efficiency of the
DNA replication machinery.
SSRP1 stimulates DNA replication origin assembly. To identify
the molecular mechanism of SSRP1-dependent somatic DNA
replication stimulation, we monitored replication origin distribution
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by DNA combing. Somatic nuclei were incubated in interphase
extract in the presence of DNA modified precursor digoxygenin-11-
dUTP (Dig-U), which labels initiation sites21 (See Methods). The
center-to-center distance between adjacent Dig-U tracks (or eyes,
which were considered to be the product of one replication fork
bubble) was considered as inter origin distance (IOD). IODs were
measured for each treatment and plotted on a graph (Fig. 2d),
revealing that somatic nuclei assembled a low number of origins
at IODs of 90–110 Kb on average (Fig. 2e) and at a density of
one origin every ~100 Kb. Strikingly, we observed a significant
increase in the number of replication origins in somatic nuclei pre-
incubated with SSRP1 and then added to interphase egg extracts.
SSRP1 stimulated the formation of origins, which assembled at
IODs of 10–15 Kb (Fig. 2e) and at a density of 6–8 origins every
100Kb. These values were similar to the ones obtained by pre-
incubation of somatic nuclei in CSF arrest mitotic egg extract
(Fig. 2d, e). Consistent with these results the amount of ORC and
MCM complexes bound to chromatin was significantly increased by
SSRP1 (Fig. 2f, g). Thus, pre-incubation of somatic nuclei with
recombinant SSRP1 was sufficient to increase the density of active
replication origins mimicking the one typically present during
embryonic DNA replication. This process was mediated by the
stimulation of ORC and MCM loading onto somatic chromatin.
The stimulatory effect was already evident at early time points
(Fig. 2f, 5 min lane), suggesting that SSRP1 acts on chromatin
before or at the time of ORC binding. SSRP1-mediated increase of
replication origin density was independent of any transcriptional
role possibly associated to the FACT complex as transcription is
absent in Xenopus egg extract.
SSRP1 averts histone H1-mediated origin assembly inhibition.
Given these results we hypothesized that replication origin
assembly on somatic chromatin could be prevented by an inhi-
bitor that SSRP1 is able to remove. Among possible candidates we
focused on somatic forms of histone H1, which can all reduce
ORC binding and replication initiation events on sperm nuclei
when overexpressed22. The histone H1 isoform present on ery-
throcyte chromatin is known as H1.0, henceforth referred as
histone H1 (refs. 22,23). We monitored histone H1 bound to
chromatin incubated in interphase and CSF-arrested mitotic egg
extracts. These experiments showed that histone H1 bound to
somatic chromatin was removed in CSF-arrested but not inter-
phase extracts (Fig. 3a). Strikingly, SSRP1 was able to promote
significant removal of histone H1 when pre-incubated with
somatic nuclei then added to interphase egg extract (Fig. 3b). The
effect was specific for histone H1 as the chromatin binding of
nucleosomal histones was unaffected (Fig. 3b). Noticeably, the
levels and the migration pattern of endogenous SSRP1 protein in
CSF-arrested mitotic extracts with high cyclin B levels were
identical to the same extracts released in interphase by addition of
CaCl2 (ref. 6), which induced cyclin B degradation, as expected
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Fig. 1 Isolation of SSRP1 as somatic nuclei replication stimulating factor. a Graph showing DNA replication kinetics of sperm (8000 n/μl) or somatic
nuclei (SN) (4000 n/μl). DNA was directly incubated in interphase egg extract (Interphase) or exposed for 30min to CSF-arrested mitotic extract,
which was then driven into interphase by 0.4mM CaCl2 addition (Mitosis+ Interphase). DNA synthesis was quantified by measuring the percentage of
α-32P-dCTP incorporation relative to the input DNA for each condition. Each point represents the mean value ± standard error of the mean (SEM). n= 3
independent experiments; p < 0.0001 when comparing mean values for all points; Two-way anova. b Graph showing DNA replication of the indicated
amounts of sperm and SN directly incubated in interphase egg extract for 120min. DNA synthesis was quantified as in (a). Bars represent mean ± SEM.
n= 3 independent experiments; **p < 0.01, ***p < 0.001 or ns when comparing mean values for the indicated samples; unpaired t test. c Schematic
representation of Xenopus egg extract fractionation. Extract was precipitated by centrifugation following incubation with increasing amount of polyethylene
glycol (PEG). Either pellet (P) or supernatant (S) fractions collected at different PEG concentrations were assayed for their ability to stimulate replication
when incubated with SN then transferred to interphase extracts in the presence of radiolabelled nucleotide. d Graph showing α-32P-dCTP incorporation
(counts per minute, cpms) in SN pre-incubated with the indicated PEG fractions for 30min and then transferred to interphase egg extract for 120min.
e Graph showing α-32P-dCTP incorporation in somatic nuclei pre-incubated with the fractions eluted from the column as described in (c) loaded with the
active PEG fraction (9%P) and then transferred to interphase egg extract for 120min.
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(Supplementary Fig. 2a), suggesting that the mechanism of CSF-
arrested extract mediated removal of histone H1 does not rely on
SSRP1. Prolonged exposure to high levels of mitosis promoting
factor (MPF) present in CSF-arrested extract, which is known to
phosphorylate histone H1 (refs. 24,25), could instead contribute to
histone H1 removal from somatic chromatin.
We then tested whether SSRP1 could directly counteract the
inhibitory effect of histone H1 on replication origins assembly. To
this end we tested the ability of purified histone H1 to inhibit
DNA replication when incubated with sperm DNA. Consistent
with previous work22, H1 binding to sperm chromatin was able to
prevent the assembly of replication origins as shown by inhibition
of ORC and MCM binding to chromatin (Fig. 3c). This correlated
with reduced replication origin number (~1–2/100 kb) placed
at an average IOD of 90 Kb, as measured by DNA combing
(Supplementary Fig. 2b, c). Accordingly, α32P-dCTP incorpora-
tion in DNA replication assays was strongly reduced by histone
H1 (Fig. 3d). Significantly, pre-incubation of SSRP1 with sperm
nuclei prevented histone H1-mediated inhibition of origin
assembly and DNA replication (Fig. 3c, d). This correlated with
increased replication origin number (~6–7/100 Kb) assembled
at an average IOD of 12–15 Kb (Supplementary Fig. 2b, c).
SSRP1 also counteracted chromatin compaction of sperm nuclei
induced by histone H1 (Supplementary Fig. 2d, e). Overall, these
experiments indicate that SSRP1 prevents histone H1-mediated
inhibition of replication origin and promotes its eviction from
somatic chromatin.
SSRP1 N-terminus directly evicts histone H1 from chromatin.
To determine the mechanism of SSRP1-mediated removal of
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showing replication time course of sperm nuclei (8000 n/μl) treated as indicated. Each point represents mean ± SEM. n= 3 independent experiments; p=
ns when comparing mean values for all samples; Two-way anova. d DNA fiber assay showing digoxigenin-dUTP (dig-dUTP) incorporation in SN incubated
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at the indicated times after addition to egg extract and blotted using the indicated antibodies. No DNA indicates absence of nuclei. SN indicates somatic
nuclei alone. Image shows typical result. g Graph showing relative quantification of signal intensity of ORC1 and MCM7 proteins loaded on chromatin at the
indicated times normalized to histone H2B. Bars represent mean intensity ± SEM. n= 3 independent experiments; p < 0.0005 when comparing mean
values for ORC1 and MCM7; t-test.
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histone H1 we verified their direct interaction. Importantly, we
showed that in vitro the SSRP1-SPT16 complex is able to interact
with histone H1 and that SSRP1 retains the ability to interact with
it even in the absence of SPT16 (Fig. 4a). To identify the mole-
cular determinants required for histone H1 interaction we gen-
erated SSRP1 deletion mutants in known SSRP1 domains
(Fig. 4b). We found that SSRP1 is able to interact with histone H1
in the presence or in the absence of SPT16 and when the HMG
domain was deleted (ΔHMG). SSRP1 protein containing a point
mutation (R213D) disrupting a second DNA binding domain26
was also able to interact with histone H1 (Fig. 4c). The N-
terminus domain (NTD) alone, which contains the conserved
pleckstrin homology (PH) protein interaction domains PH1 and
PH2 involved in hetero-dimerization with SPT16 (ref. 27), was
equally able to bind histone H1 (Fig. 4c). Instead, the N-terminus
deletion mutant (ΔNTD), lacking the first 177 aa of the N-
terminus completely abolished the binding of SSRP1 to histone
H1 (Fig. 4c). These experiments define an important function for
the conserved NTD of SSRP1 in binding histone H1 and revealed
an additional histone chaperone role for SSRP1, which is already
known to interact with histone H2A-H2B and H3-H4 dimers27.
How these activities are coordinated with histone H1 binding
in vivo remains to be investigated.
Next, we tested the ability of the different mutants to promote
replication of somatic nuclei, histone H1 eviction and DNA
replication origin formation. We found that the ΔNTD mutant
protein could not promote somatic nuclei replication (Fig. 5a, b)
and origin assembly (Fig. 5c). Instead, pre-incubation of somatic
nuclei with SSRP1 NTD domain was sufficient to stimulate DNA
replication (Fig. 5a, b) and origin assembly (Fig. 5c). ΔHMG and
R213D mutations, instead, did not affect the ability of SSRP1 to
stimulate somatic nuclei replication (Fig. 5a, b) and replication
origin assembly (Fig. 5c). These results indicated that SSRP1 NTD
was responsible for the stimulation of origin assembly on somatic
nuclei. Accordingly, the ΔNTD mutant failed to induce histone
H1 eviction from somatic nuclei and to counteract H1-mediated
replication origin assembly inhibition (Fig. 5d, e). Instead, the
NTD alone could significantly promote the eviction of histone H1
bound to somatic nuclei when pre-incubated with them (Fig. 5f).
As the NTD alone is able to bind chromatin (Fig. 5f) it is possible
that histone H1 removal is mediated by NTD binding both H1
and DNA, weakening histone H1 interaction with linker DNA.
Although SSRP1 alone is capable of removing histone H1 from
chromatin through its NTD we cannot completely rule out the
requirement of endogenous SPT16 for this task, as we could not
deplete SPT16 with our anti Xenopus SPT16 antibody. This was
likely due to the high concentration of SPT16 in egg extract
(~620 nM)20. However, we believe that the participation of SPT16
in H1 removal is unlikely as SSRP1 is able to bind somatic nuclei
in the absence of detectable SPT16 before nuclei incubation in
egg extract (Supplementary Fig. 3a). Furthermore, recombinant
SSRP1 does not stimulate further recruitment of endogenous
SPT16 onto chromatin when somatic nuclei preloaded with
SSRP1 are transferred to egg extract (Supplementary Fig. 3b).
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SSRP1 delays MBT onset. Having established the roles of
SSRP1 and histone H1 in regulating the assembly of replication
origins we asked whether these activities affect the physiological
regulation of replication origin assembly during embryonic
development. Somatic replication cycles are established at MBT,
when the number of embryonic replication origin is significantly
reduced. This coincides with the elongation of the cell cycle
through the downregulation of Cdk1 activity, which is modulated
by the inhibitory phosphorylation of tyrosine 15 (pTyr 15)28.
Phosphorylation of tyrosine 15 reflects the activation of Chk1 at
MBT, which contributes to cell cycle progression regulation in
post-MBT cycles28. Expression of somatic histone H1 proteins
H1A and H1B, which are highly similar to histone H1.0, starts
around stage 5 and rapidly increases at MBT29 whereas SSRP1
protein levels, together with SPT16, decrease at this stage (Sup-
plementary Fig. 4) consistent with previous MS analysis29. To test
whether histone H1 proteins expression and decreasing levels of
SSRP1 protein are determinant for the establishment of somatic
replication mode, we injected Myc-tagged SSRP1 mRNA in fer-
tilized eggs and monitored their development following the
number of synchronous divisions-only for about 450 min from
fertilization until MBT onset, which normally occurs between
cycles 12 and 14 (Fig. 6a and Supplementary Movie 1). Strikingly,
SSRP1 overexpression induced a sharp delay in the onset of the
MBT, as shown by the increase in the number of rapid syn-
chronous divisions from 14 to 15 in all injected embryos com-
pared to buffer injected ones (Fig. 6b). The injection of SSRP1 did
not affect the total level of histone H1 protein expressed in post-
MBT embryos when compared to buffer injected control embryos
at similar stage (Supplementary Fig. 5a). Co-injection of an excess
of histone H1, instead, suppressed SSRP1 induced MBT delay
(Supplementary Fig. 5b, c).
Consistent with SSRP1-dependent induction of extra synchro-
nous pre-MBT cycles, the DNA content in embryos injected with
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SSRP1 also increased compared to embryos injected with buffer
only (Supplementary Fig. 6). Accordingly, phosphorylation of
Cdk1 Tyr15 was delayed (Fig. 6c), especially between stage 8 and 9
in which embryos were sampled every 30 min to better monitor
the effect on MBT timing induced by SSRP1. Injection of the
mRNA of the ΔNTD mutant, which cannot interact with and evict
histone H1 from chromatin, was unable to delay MBT, promote
extra synchronous cell divisions (Fig. 6d, e and Supplementary
Movie 2), increase the DNA content (Supplementary Fig. 6) or
delay Cdk1 Tyr15 phosphorylation (Fig. 6f). Significantly, the
NTD alone was instead able to promote extra synchronous cycles
and MBT delay (Fig 6g, h and Supplementary Movie 3), increase
the DNA content (Supplementary Fig. 6) and delay Cdk1 Tyr15
phosphorylation (Fig. 6i). Of note, the expression of the injected
Myc-tagged SSRP1, ΔNTD and NTD proteins persisted in post-
MBT embryos suggesting that their action continued during
development (Fig. 6c, f, i).
Intriguingly, SSRP1 injection promoted general transcription
stimulation of a number of genes normally expressed at MBT
as shown by quantitative Polymerase Chain Reaction (qPCR)
(Supplementary Fig. 7). SSRP1 dependent transcriptional
stimulation started around MBT and continued in post-MBT
embryos (Supplementary Fig. 7). Among the stimulated genes
there were genes suppressed by histone H1, including xMyoD
and BMP4 (ref. 30) (Supplementary Fig. 7).
SSRP1 accelerates development by increasing cell cycle speed.
Surprisingly, SSRP1 induced MBT delay did not disturb post-MBT
development events. This is contrast with other interventions that
stimulate active replication origins formation on somatic nuclei,
which lead to embryo death at gastrulation7. Strikingly, instead,
we observed a marked increase of post-MBT development speed.
Faster development in SSRP1-injected embryos was harmonic as
all major anatomical structures, including the eye vesicle, the
neural tube and the tail were normally formed. The effect of
SSRP1 could be easily noticed 48 h post fertilization (pf), when
SSRP1-injected embryos appeared to be at stage 42–43, normally
reached 72 h pf, instead of stage 32–33, typically reached 48 h pf
(Fig. 7a). For a quantitative readout of development speed we
monitored tadpole length, showing that at 48 h pf the average
length of SSRP1-injected embryos was significantly higher than
a
b
c
e
d
f
N
T
D
 In
pu
t ORC1
MCM7
ORC2
ΔNTD (Flag)
H1
H2B
H1In
pu
t H
1
N
o 
D
N
A
+ – + – +
Buffer ΔNTD
Chromatin
Pol alpha
M 
   S
No
 D
NA
No
 D
NA
SN
Bu
ffe
r
Bu
ffe
r
SS
RP
1
ΔN
TD
ΔH
MG
R2
13
D
NT
D
M 
   S
No
 D
NA
Bu
ffe
r
SS
RP
1
ΔN
TD
ΔH
MG
R2
13
D
NT
D
SS
RP
1
ΔN
TD
DH
MG
R2
13
D
NT
D
ORC1
MCM7
PCNA
H2B
Chromatin
37
150
100
75
15
ΔN
T
D
 In
pu
t
H1
H2B
SN 30 45 60 30 45 60 minN
o 
D
N
A
Buffer ΔNTD 
ΔNTD (Flag)
Chromatin Chromatin
50
4
3
2
1
0
F
ol
d 
ch
an
ge
(n
or
m
al
iz
ed
 to
 b
uf
fe
r)
25
15
100
75
50
25
15
50 25
15 H2B
H1
NTD (Flag)
SN 30 45   60 30 45 60 minN
o 
D
N
A
Chromatin Chromatin
Buffer NTD
Fig. 5 SSRP1 N-Terminal domain dependent stimulation of DNA replication through histone H1 chromatin eviction. a Representative autoradiography of
a DNA replication assay showing α-32P-dCTP incorporation for 120min in SN pre-incubated with 200 ng/μl recombinant SSRP1 or equimolar amounts of
its mutated versions, as indicated. b Graph indicating fold change in somatic DNA replication efficiency relative to buffer considered as 1. SN were pre-
incubated with 200 ng/μl recombinant SSRP1 or equimolar amounts of its mutated versions as indicated. Bars represent mean ± SEM. n= 3 independent
experiments; p < 0.005 when comparing all values. Two-way anova. c WB of chromatin isolated at 60min after addition to interphase egg extracts of SN
pre-incubated with 200 ng/μl recombinant SSRP1 or equimolar amounts of its mutant versions and probed with the indicated antibodies. d WB of
chromatin isolated at the indicate times from interphase egg extracts supplemented with SN pre-incubated with Flag-ΔNTD or control buffer. e WB of
chromatin isolated from interphase egg extracts incubated for 60min with SN exposed to Flag-NTD or control buffer in the presence or absence of purified
histone H1. f WB of chromatin isolated at the indicate times from interphase egg extracts incubated with somatic nuclei exposed to Flag-NTD or
control buffer.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-15180-5 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:1345 | https://doi.org/10.1038/s41467-020-15180-5 | www.nature.com/naturecommunications 7
control embryos and more typical of tadpoles of more advanced
stages (Fig. 7b). SSRP1 induced acceleration persisted throughout
post-MBT development and stopped around 96 h pf with embryos
readjusting to a normal development speed and size, likely due to
the fading of exogenous protein expression.
To understand the mechanism responsible for this accelerated
development we measured the duration of post-MBT cell cycles
by monitoring different areas of tadpoles with remaining
synchronous divisions31. In control embryos pre-MBT cycles
lasted around 35 min, whereas cycles 13, 14 and 15 progressively
extended lasting up to 45–65 min. Cell cycle decelerated
consistently at post-MBT cycle 16, the last one that could be
monitored by non-invasive imaging, which lasted up to 150 min.
Notably, we found that the average length of post-MBT cell cycles
in embryos injected with SSRP1 was strongly reduced, lasting up
to 50% less compared to control embryos (Fig. 7c).
In contrast, the expression of ΔNTD mutant protein was
unable to promote development acceleration (Fig. 7d, e).
Tadpoles exposed to ΔNTD mRNA developed with normal pace
and reached similar lengths at 48 h pf with only a slightly negative
effect on embryo length. Consistently, the ΔNTD did not affect
the duration of the cell cycle (Fig. 7f).
The expression of equivalent levels of mRNA encoding for the
NTD was instead able to promote efficient developmental
acceleration, which was mostly visible at 24 h pf (Fig. 7g, h)
likely due to a higher efficiency towards H1 removal and a more
limited stability of the injected NTD fragment. The NTD
expression had also marked effects on the average cell cycle
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duration, which was significantly reduced as in the case of SSRP1
injection (Fig. 7i).
SSRP1 promotes origin assembly and DNA transcription
in vivo. To verify whether the acceleration of the cell cycle in
post-MBT embryos by SSRP1 was due to the stimulation of DNA
replication we monitored replication dynamics in embryos by
DNA combing. To this end we made extracts from post-MBT
stage embryos injected with buffer or SSRP1 mRNA (Supple-
mentary Fig. 8a). These extracts contain nuclei that are able to
replicate their DNA in vitro in the presence of an ATP regen-
eration system, reproducing DNA replication dynamics typical of
the stage they derived from32. We pulse labeled DNA replication
for short time using biotin-dUTP and monitored DNA replica-
tion initiation events and IODs by DNA combing as in Figure 2d.
We observed that replication origins in post-MBT embryos
injected with buffer had an average IOD of 17.6 ± 0.7 Kb and a
density of ~4–5 origins every 100 Kb (Supplementary Fig. 8b, c),
similar to what previously reported32. In embryos injected with
SSRP1, instead, we observed a significant stimulation of replica-
tion origin assembly with origins placed at an average IOD of
10.1 ± 0.3 Kb and at density of ~8–9 origins every 100 Kb (Sup-
plementary Fig. 8b, c). These results are compatible with reduced
length of S-phase and therefore with shorter post-MBT cell cycle
duration. Notably, SSRP1 injection was also able to stimulate de
novo RNA transcription, which we measured by monitoring
ethynyl-uridine (EU) incorporation in RNA synthesized in post-
MBT extracts (Supplementary Fig. 8d, e). This stimulation was in
agreement with qPCR data of early transcribed genes in SSRP1-
injected embryos (Supplementary Fig. 7). As replication origins
might interfere with transcription events inducing DNA damage
as result of DNA transcription and DNA replication conflicts33,
we monitored the occurrence of DNA double strand breaks by
measuring the levels of H2AX phosphorylation34 in embryos with
accelerated development. Although phospho-H2AX levels could
be detected in tissue sections of embryos subjected to mild
ionizing radiation, SSRP1 did not induce measurable levels of
H2AX phosphorylation (Supplementary Fig. 9). These results
suggest that stimulation of DNA replication origin assembly by
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SSRP1 during development does not cause significant DNA
damage and is therefore compatible with ongoing transcription,
consistent also with the normal morphology of fast developing
embryos injected with SSRP1 or NTD.
Discussion
Our findings indicate that somatic nuclei cannot be efficiently
replicated in interphase egg extract, in which replication factors
are not limiting, due to a non-permissive status for pre-RC
assembly that prevents efficient loading of ORC and MCM
complexes onto somatic chromatin. We show that: (1) histone
H1 bound to somatic chromatin is responsible for this non-
permissive status; (2) SSRP1 promotes the assembly of active
replication origins onto somatic chromatin DNA by removing
histone H1; (3) the histone H1 binding region of SSRP1 NTD is
necessary to counteract histone H1; (4) SSRP1 protein levels
decay at MBT; (5) SSRP1 and its NTD domain are able to delay
MBT onset; (6) persistent SSRP1 levels promote faster cell
divisions and embryonic development acceleration; (7) delayed
MBT and accelerated development induced by SSRP1-mediated
increase in origin assembly do not lead to DNA damage
accumulation.
Non-permissive chromatin status is probably ensured by tight
binding of histone H1 to linker DNA forming high order chromatin
structures with restricted nucleosome mobility35 that limit the
access of the ORC complex to DNA (Fig. 8). Consistent with this
histone H1 in mammalian cells stabilizes nucleosome occupancy on
more than 50% of AT rich regions21, which are preferential sites for
ORC complex binding36. Therefore, histone H1 removal from
somatic chromatin and consequent nucleosome destabilization at
these sites by SSRP1 might facilitate ORC complex DNA binding
leading to high replication origin assembly typical of embryonic
cycles. Somatic histone H1 proteins H1A and H1B, which together
with histone H1.0 share common binding mode to linker DNA37,
are expressed around MBT and constitute the major forms of
somatic histone H1 at this stage23. Embryonic maternal histone
H1M, which apparently does not interfere with replication origin
assembly, is instead lost at MBT35. The presence of high SSRP1
levels before MBT when somatic histone H1 levels start to rise
might counteract premature incorporation of histone H1 into
chromatin, avoiding disruption of rapid DNA replication cycles.
Parallel SSRP1 decay and histone H1 increase could cooperate to
determine the onset of somatic cycles post MBT (Fig. 8). SSRP1
persistence at lower levels might continue to modulate histone H1
incorporation into chromatin throughout development probably at
specific loci even after declining. The interaction with histone H1
might take place between the PH domains at the N-terminal region
of SSRP1 and the globular portion of histone H1, which binds the
DNA at the nucleosome entry-exit point37. This could weaken the
binding of histone H1 to DNA promoting its release. Alternatively,
SSRP1 might interact with the tail of histone H1 disengaging it from
the linker DNA37. Structural analysis of SSRP1 together with his-
tone H1 is required to discriminate between these models.
Previously, it was shown that the lengthening of the cell cycle
and the resulting asynchronous cell division that begins at the
MBT is due, at least in part, to a decline in the amounts of four
limiting replication factors Cut5, RecQ4, Treslin, and Drf1 (ref. 7).
MBT delay can indeed be obtained by overexpressing these four
factors7. This, however, leads to embryo death around gastrula-
tion7. Surprisingly, persistent high levels of SSRP1 not only pro-
mote MBT delay without interfering with normal development
but also lead to its dramatic acceleration due to reduced length of
DNA synthesis and cell cycle (Fig 8). These observations suggest
that replication initiation factors are sufficient to support DNA
replication at MBT in the presence of persistent expression
of SSRP1.
SSRP1-mediated delay of MBT and accelerated development
might be a physiological phenomenon, possibly activated in
environmental conditions requiring faster development, a
response present in some amphibian species38. The faster pace of
DNA synthesis imposed by SSRP1 might indirectly impact on
the cell cycle delaying the activation of CHK1, which coordinates
entry into mitosis with ongoing DNA synthesis at MBT28 by
modulating the levels of Drf1 (ref. 39) and Cdk1 tyr 15 phos-
phorylation through Cdc25A40 (Fig. 8). How faster cell cycle is
coupled to rapid cell growth remains to be established.
Unexpectedly, SSRP1-mediated MBT delay and accelerated
development due to stimulation of DNA replication does not
++SSRP1 
CTRL
SSRP1 
MBTH1 
Stage 2 4 6 7 8 9 10
Fig. 8 Proposed model. In vitro SSRP1 suppresses histone H1 chromatin association and histone H1-mediated inhibition of DNA replication origins
assembly. In vivo SSRP1 levels decrease around MBT when somatic forms of histone H1 start to be expressed. Overexpression of SSRP1 delays MBT onset.
Persistent expression of SSRP1 in post-MBT embryos promotes faster somatic cell cycles and accelerated development. See text for more details.
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interfere with active transcription, as shown by the absence of
DNA double strand breaks, which can occur when DNA repli-
cation forks collide head on with transcription units33.
Intriguingly, SSRP1 is enriched at transcription start sites
(TSSs)15 whereas histone H1 is selective depleted from these41.
Consistent with this arrangement we observe general SSRP1
dependent transcription stimulation at MBT, which might in part
be due to histone H1 removal from TSSs. SSRP1-mediated sti-
mulation of replication origin assembly might take place at TSSs,
where co-directional activation of replication forks and tran-
scription units could avert head-on collisions, and therefore,
DNA damage. Alternatively, SSRP1 itself might help to resolve
conflicts between transcription and DNA replication as already
shown for the FACT complex in other organisms42.
Altogether these results reveal a key regulatory epigenetic
mechanism that coordinates DNA replication with cell cycle and
development in vertebrate organisms. This pathway could be an
attractive target for cancer therapy as its modulation might
restore normal histone H1 incorporation onto chromatin in
SSRP1 overexpressing tumors and in cancer stem cells bearing
reduced levels of histone H1 (refs. 16,17), thus limiting DNA
replication and cell proliferation.
Methods
Experimental model. Eggs derived from Xenopus laevis frogs were used as
experimental model system. Collection of eggs from the female frogs was per-
formed in a non-invasive way following chorionic gonadotropin (Sigma, CG10)
injection, complying with all relevant ethical regulations for animal testing and
research. Occasional surgical procedures were performed on the male frogs to
harvest sperm nuclei. Experimental protocols were approved by IFOM Animal
Welfare committee and the Italian Ministry of Health. Part of the experiments also
were conducted at Clare Hall Laboratories, London Research Institute (LRI) under
LRI and UK Home Office authorization for the use of amphibians. The number of
animals used was kept to a minimum and was calculated taking into account the
number eggs required to obtain the cytoplasmic extract needed for the experiments
described. The animals were kept in highly regulated and monitored conditions
with room and water temperature at 19 °C. Basic husbandry requirements were
provided by the IFOM Xenopus facility and LRI amphibians facility.
Preparation of egg and embryo extracts. Xenopus mitotic egg extracts (CSF
extracts) were prepared as previously described43. Briefly, eggs were laid and col-
lected in MMR solution (100 mM NaCl, 2 mM KCl, 1 mM MgCl2, 2 mM CaCl2,
0.1 mM EDTA, 5 mM HEPES, pH 8). The jelly coat of eggs was removed by
incubation in 2% cysteine in Murray salt solution (100 mM KCl, 1 mM MgCl2, 0,
1 mM CaCl2). The dejellied eggs were then washed three times with XB wash buffer
(100 mM HEPES-KOH, pH 7.8, 500 mM sucrose) and three times with CSF-XB
buffer (100 mM KCl, 5 mM EGTA, 2 mM MgCl2). Wash buffer was then poured
off and 10 mg/ml of cytochalasin B (SIGMA) in DMSO and LPC protease inhi-
bitors (30 mg/ml each of leupeptin, pepstatin and chymostatin) were added. Eggs
were packed for 1 min at 1000 × g in a swing bucket rotor at 16 °C. Excess liquid on
top of the packed eggs was removed and the eggs were crushed by centrifugation in
a swing rotor at 20,000 × g for 14 min. The resulting cytoplasmic extract (middle
golden yellow layer) was removed by puncturing the side of the tube with a 19-
gauge needle and slowly removing the cytoplasmic layer with a 2 ml syringe. This
extract was placed in a 5 ml polypropylene round-bottomed tube (Falcon 2063).
Cycloheximide 0.2 mg/ml (Calbiochem) was then added. Energy mix (375 mM
creatine phosphate, 50 mM ATP, 10 mM EGTA, 50 mM MgCl2) was added at 1:50
dilution; LPC protease inhibitors mix (30 mg/ml each of leupeptin, pepstatin and
chymostatin) and cytochalasin B (10 mg/ml) were added at 1:1000 dilution. The
extract was then gently mixed and centrifuged for 15 min at 4 °C. The resulting
extract was removed by syringe as above, and placed in a new tube ready for use.
CSF egg extracts were induced to enter interphase by addition of 0.4 mM CaCl2
and used as indicated in text and figure legends.
Embryonic nucleo-cytoplasmic extracts were prepared as described32 with some
modifications. Briefly, 400 dejellied late blastula (stage 9) embryos were washed in
embryo extraction buffer (10 mM Hepes, pH 7.7 KOH, 100 mM KCl, 50 mM
Sucrose, 1 mM MgCl2, 0.1 mM CaCl2 and spun at 700 × g for 1 min to pack
embryos without crushing. Excess liquid was removed and embryos were
centrifuged at 17,000 × g for 10 min at 4 °C. The two middle phases (yellow
containing cell cytoplasm and gray containing the nuclei) were isolated with a
needle and combined.
DNA templates. Demembranated sperm nuclei were prepared as previously
described44. Briefly, X. laevis males were primed with 50 U PMSG (Folligon) 7 days
in advance and with 300 U HCG the day before testis dissection. Testis were
isolated and collected in EB buffer (50 mM HEPES-KOH, pH 7.6, 50 mM KCl,
5 mM MgCl2, 5 mM EGTA, 2 mM β-mercaptoethanol), rinsed three times in ice-
cold EB buffer and finely chopped with a razor blade. The material was then
transferred to 15 mL Falcon tube and spun for 5 min in a swinging-bucket rotor at
4250 × g at 4 °C. The pellet was then resuspended in 1.5 mL of SuNaSp buffer at
room temperature (0.25 M sucrose, 75 mM NaCl, 0.5 mM spermidine, 0.15 mM
spermine). To remove membranes lysolecithin 2 mg/mL (SIGMA) was added and
incubated for 10 min at room temperature. Reaction was stopped by adding 3%
BSA (SIGMA). The pellet was resuspended again in 1 mL ice-cold EB and spun at
2000 × g for 5 min at 4 °C. The final pellet was resuspended in 400 μl of EB
suplemebted with 30% glycerol.
Erythrocyte somatic nuclei were purified from two female frogs. Blood was
collected in 10 ml of Barth solution (88 mM NaCl, 2 mM KCl, 0.82 mM MgCl2,
10 mM Hepes pH 7.4) and, immediately after, diluted into 10 ml ice-cold 0.6×SSC
buffer (150 mM NaCl, 15 mM Na citrate, pH 7.0) supplemented with heparin
(10 mg/ml). The diluted blood was underlaid with 0.5 volumes of Ficoll 5.7% w/v in
0.6 × SSC-heparin solution and centrifuged at low speed for 15 min at 4 °C. The red
pellet was resuspended in 0.6 × SSC and centrifuged through Ficoll. The resulting
pellet was washed three times in nuclear isolation buffer (NIB) (250 mM sucrose,
25 mM NaCl, 10 mM PIPES, 1.5 mM MgCl2, 0.5 mM spermidine, 0.15 mM
spermine) at pH 7.0 and resuspended at 1 × 108 cells/ml. For demembranation,
erythrocyte somatic nuclei were diluted to 4 × 107 cells/ml in NIB at 23 °C. An
equal volume of NIB containing 40 μg/ml lysolecithin and two volumes of trypsin
type XIII (1 μg/ml) solution (SIGMA) were added. After 5 min, 10 μg/ml soy bean
trypsin inhibitor (SIGMA) and 0.4% BSA were added. Nuclei were centrifuged at
1000 × g, washed twice with NIB and resuspended in NIB at 200,000 nuclei/μl,
supplemented with 30% glycerol and frozen in small aliquots in liquid nitrogen.
Chromatin isolation from egg extract. To isolate chromatin fractions, sperm or
erythrocyte nuclei (4000 nuclei/μl) were added to 30 μl egg extracts and incubated
at 23 °C for the indicated time. Samples were diluted with 10 volumes of ice-cold
EB (100 mM KCl, 2.5 mM MgCl2 and 50 mM HEPES-KOH pH 7.5) containing
0.25% NP-40 and centrifuged through a 0.5 M sucrose layer at 10,000 × g for 5 min
at 4 °C. Pellets were washed once with EB and resuspended in SDS-PAGE sample
buffer. Proteins were then resolved by SDS-PAGE and monitored by WB.
Replication reactions. DNA replication in Xenopus egg extract was performed as
previously described34. Briefly, sperm or erythrocyte nuclei (400-8000 nuclei/µl)
were added to 20 µl interphase egg extract supplemented with 0.1 µl of α-32P-dCTP
(250 mCi; 3000 Ci/mmol) and incubated at 23 °C. Reactions were stopped with
Stop buffer (8 mM EDTA, 80 mM Tris pH 8.0, 1% w/v SDS), supplemented with
1 mg/ml Proteinase K and incubated at 50 °C for 2 h. Samples were treated with
RNase (0.6 mg/ml) to degrade any trace of RNA. Genomic DNA was phenol/
ethanol exracted and then separated from unincorporated nucleotides by electro-
phoresis through a 0.8% agarose gel. The gel was fixed in 30% TCA for 20 min,
dried and exposed for autoradiography. For quantification of DNA replication, the
gels were exposed to a phosphoscreen (GE Healthcare). The recorded radioactive
signal was monitored within a phosphoImager (Typhoon) and measured with
ImageQuant software. Alternatively, absolute amount of replicated DNA was
quantified as previously described45–47. Briefly samples were precipitated with 4 ml
of 4 °C 10% TCA for at least 30 min at 4 °C. A fraction of the precipitated sample
(40 μl) was spotted spotted on paper filter for measurment of total 32P. The
remainder of the sample was filtered through a glass fiber filter, which was washed
twice with 8 ml of 4 °C 5% TCA and then with 8 ml of ethanol. Each filter emission
was quantified through a beta-counter. Quantification of replicated DNA was
obtained by dividing the 32P incorporated into DNA captured on the glass fiber
filter by the total 32P on the paper filter, yelding the percentage of total 32P
incorporated into DNA. For embryo nuclei replication monitoring through DNA
combing (see below) nucleo-cytoplasmic lysates were supplemented with energy
mix (7.5 mM creatine phosphate, Creatine kinase 1 mM ATP) and 20 μM biotin-
dUTP to monitor DNA replication at 23 °C for 6 min.
RNA transcription labeling in Xenopus embryos. To label de novo synthesis of
RNA in post-MBT Xenopus embryos embryonic nucleo-cytoplasmic extracts were
prepared as described above. Click-iT RNA Alexa Fluor 594 (C10330) and Alexa
Fluor 488 (C10329) imaging kits were adapted for application in Xenopus
embryonic lysates. Briefly, click-iT EU (5-ethynyl Uridine) was added to Xenopus
embryonic lysates at a final concentration of 1 mM for 30 min. Total RNA was
extracted by applying TRIzol reagent to lysates (Invitrogen) followed by Direct-zol™
DNA/RNA MiniPrep kit (Zymo Research) according to manufacturer instructions.
Then, 10 μg EU-labeled RNA were incubated with a 1×working solution of click-iT
reaction cocktail, containing the Alexa Fluor 594 azide and CuSO4 for 1 h in the
dark at room temperature. The reaction was repeated with the Alexa Fluor 488
azide to evaluate consistency of labeling. The labeled RNA was precipitated with
ethanol and re-suspended in nuclease-free water. Samples were separated on 1%
TAE agarose gel and total RNA was visualized with ethidium bromide staining to
monitor RNA quality. Total fluorescence of labeled RNA in each lane was detected
and quantified with fluorescence detection system (Bio-rad).
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Extract fractionation and protein identification. Egg extract was fractionated by
differential precipitation with PEG as previously described with some modifica-
tions48. Briefly, extract was diluted fourfold in LFB buffer (40 mM Hepes-KOH pH
8.0, 20 mM K2HPO4-KH2PO4 pH 8.0, 2 mM MgCl2, 1 mM EGTA, 2 mM DTT,
10% w/v Sucrose, 1 µg/µl each of Leupeptin, Pepstatin, Aprotin). The diluted
extract was centrifugated for 40 min at 80,000 × g in a swing out rotor at 4 °C. The
supernatant was carefully transferred to avoid pellet contamination and supple-
mented with 50% PEG 6000 solution (SIGMA) to give a final concentration of 9%
PEG. Samples were incubated on ice for 30 min and precipitated proteins removed
by spinning at 10,000 × g for 10 min in a fixed-angle rotor. The supernatant was
recovered and the pellet resuspended in LFB at 5× concentration with respect to
undiluted extract. After collecting the aliquote, the supernatant was used for
subsequent precipitations. Active fractions were further separated on phospho-
celluose column (Whatmann P11) equilibrated with 0.1 M NaCl, 20 m HEPES-
KOH (pH 7.9), 0.5 m EDTA, 10 mM DTT, 10% glycerol and eluted with NaCl
gradient in the same buffer. Each fraction was then tested for its ability to induce
replication of somatic erythrocytes nuclei in interphase extract. Each replication
reaction was performed by pre-incubating 4 µl of each fraction with erytrocyte
nuclei for 30 min at 23 °C. Reaction was then supplemented with 15 µl of inter-
phase extract and incubated for 120 min in the presence of α-32P-dCTP. Active
fractions were subjected to protein identification by mass spec analysis.
Mass spectrometry. Approximately 50 μg of proteins from active fractions were
transferred to YM-10 Microcon filters (Cat No. MRCF0R010, Millipore) and
centrifuged at 14,000 × g for 20 min. 60 μl of 8 M urea in 0.1 M Tris-HCl, pH 8.5
(UT) were added and the sample was reduced by adding 10 μl of 100 mM DTT for
30 min at room temperature. Samples were centrifuged at 14,000 × g for 20 min.
Then, 60 μL UT and 10 μL of 55 mM iodoacetamide were added to the filters and
incubated in the dark for 20 min. Filters were washed twice with 100 μL of UT.
1.2 μg of Lys-C (Wako) were added and incubated overnight at room temperature.
Subsequently, 100 Tris-HCl, pH 8.5 were added to dilute urea concentration and
0.6 μg of trypsin were added in 100 μL 0.1 M Tris-HCl, pH 8.5. Samples were
incubated at room temperature for 6 hours, centrifuged at 14,000 × g for 20 min
and finally 50 μL of 0.5 M NaCl were added to the filter and the released peptides
were collected by centrifugation. The resulting peptides were desalted on a C18
home made StageTip. Peptides were resuspended in 60 μL of Buffer A (2 % ACN,
0.1% formic acid) and 1 μL was injected for every technical replica. Peptides
separation was achieved with a linear gradient from 95% solvent A (2% ACN, 0.1%
formic acid) to 40% solvent B (80% acetonitrile, 0.1% formic acid) over 30 min and
from 40% to 100% solvent B in 2 min at a constant flow rate of 0.25 μL/min, with a
single run time of 35 min.
MS data were acquired using a data-dependent top 12 method, the survey full
scan MS spectra (300–1750 Th) were acquired in the Orbitrap with 70000
resolution, AGC target 1e6, IT 120 ms. For HCD spectra resolution was set to
35000, AGC target 1e5, IT 120 ms; normalized collision energy 25% and isolation
width of 3.0m/z. MS data were acquired using a data-dependent top10 method for
HCD fragmentation. Survey full scan MS spectra (300–1750 Th) were acquired in
the Orbitrap with 70000 resolution, AGC target 1e6, IT 120 ms. For HCD spectra
resolution was set to 35000, AGC target 1e5, IT 120 ms; normalized collision
energy 25% and isolation width 3.0 m z-1. Raw data were processed with
MaxQuant version 1.5.1.2. For protein identification the raw data were processed
using Proteome Discoverer (version 1.4.0.288, Thermo Fischer Scientific).
MS2 spectra were searched with Mascot engine against custom Xenopus laevis
revised version (according to Tikira Temu, Matthias Mann, Markus Räschle,
Jürgen Cox, Homology-driven assembly of NOn-redundant protEin sequence sets
(NOmESS) for MS, with the following parameters: enzyme Trypsin, maximum
missed cleavage 2, fixed modification carbamidomethylation (C), variable
modification oxidation (M) and protein N-terminal acetylation, peptide tolerance
10 ppm, MS/MS tolerance 20 mmu. Peptide Spectral Matches (PSM) were filtered
using percolator based on q-values at a 0.01 FDR (high confidence). Scaffold
(version Scaffold_4.3.4, Proteome Software Inc., Portland, OR) was used to validate
MS/MS based peptide and protein identifications. Peptide identifications were
accepted if they could be established at >95.0% probability by the Peptide
Prophet algorithm with Scaffold delta-mass correction. Protein identifications were
accepted if they could be established at >99.0% probability. Protein probabilities
were assigned by the Protein Prophet algorithm. Proteins that contained similar
peptides and could not be differentiated based on MS/MS analysis alone were
grouped to satisfy the principles of parsimony. Proteins sharing significant peptide
evidence were grouped into clusters. MS was initially performed at Clare Hall
Laboratories and then validated in IFOM.
DNA combing. For somatic nuclei (4000 n/µl) DNA replication reactions were
carried out in egg extract supplemented with 1/20 of energy regeneration mix and
1/50 of cycloheximide solution described above and 20 µM digoxigenin-11-dUTP
(Roche) for 75 min in the presence of 5 µg/µl aphidicolin. For sperm nuclei
(8000 n/µl) DNA replication reactions were carried out for 10 min in the presence
of 20 µM biotin-16-dUTP (Roche). For embryonic nuclei embryonic lysates con-
taining nuclei isolated from 200 dejellied blastula embryos (stage 9) injected at
1-cell stage with buffer or Myc-SSRP1 mRNA, as described above, were incubated
for 6 min in the presence of 20 µM biotin-16-dUTP. DNA replication reactions
were stopped by adding 10 volumes of ice-cold 1× PBS buffer. Nuclei were then
pelleted on a sucrose cushion by centrifugation at 1000 × g at 4 °C for 7 min. Nuclei
pellets were resuspended in 50 µl of PBS, mixed with 50 µl 1% low-melting-point
agarose (Lonza) and transferred to a casting mould to prepare the plugs. Plugs were
then treated with 2 mg/ml of proteinase K (Roche) in digestion buffer (0.5 M
EDTA, pH 8, 10% sarkosyl) at 50 °C overnight. Treatment was repeated the day
after with freshly prepared proteinase K solution. Subsequently, plugs were washed
four times for 1 h each wash in TE buffer supplemented with 50 mM EDTA. The
TE buffer was replaced with 50 mM MES (pH 5.7) (Sigma-Aldrich, M5287 and
M5057) and plugs were incubated at 65 °C for 15 min. Once melted, the plugs were
treated with 4 units of β-agarase (New England Biolabs) at 42 °C overnight. DNA
from the resulting solution was combed on silanized slides (Genomic Vision) at a
constant speed of 18 mm/min using the combing apparatus (Genomic Vision).
Slides were then dried at 65 °C for 30 min. DNA was fixed onto the slides by a 5
min incubation in methanol:acetic Acid (3:1) and denatured in 2.5 M HCl for 30
min. Slides were sequentially incubated in 70%, 90% and 100% EtOH for 3 min
each time, washed three times for 5 min in PBS, dried and blocked for 1 h in
BlockAid™ blocking solution (B10710, Invitrogen) at 37 °C. Digoxigenin was
detected with mouse anti-digoxigenin FITC antibody (Sigma-Aldrich) used at 1:20
dilution for 1 h at 37 °C. Biotin was detected with Streptavidin Alexa Fluor 594-
conjugated antibody (S-11227, Thermo Fisher Scientific) used at 1:20 dilution for 1
h at 37 °C, followed by anti-streptavidin biotinylated antibody (BA-0500, Vector
Laboratories) used at 1:20 dilution for 1 hr at 37 °C. This procedure was repeated
twice, then followed by staining with an anti-ssDNA antibody (MAB3034,
MerckMillipore) used at 1:300 dilution for 1 h at 37 °C. Secondary antibodies Alexa
Fluor 488 conjugated rabbit anti-mouse (A-11059, Thermo Fisher Scientific) fol-
lowed by Alexa Fluor FITC conjugated goat anti-rabbit for signal enhancement (F-
2765, Thermo Fisher Scientific) were used at 1:50 with each incubation lasting 1 h.
In between all antibody incubations, slides were washed twice for 2 min in PBS+
0.05% Tween 20. All antibodies were diluted in BlockAid™ blocking solution.
Finally, the slides were washed three times with PBS, 0.05% Tween 20, once again
in PBS, and then mounted on a microscope slide with Mowiol mounting medium
(Sigma-Aldrich). Image acquisition was performed with a fully motorized micro-
scope equipped with a camera and controlled by MetaMorph (Universal Imaging
Corporation). Inter-origin distances between Dig-dUTP tracks or biotin-dUTP
tracks, were measured using the MetaMorph software, and micrometer values were
expressed in kilobases using as conversion factor 1 µm= 2.59 kb.
Plasmid construction. Human SSRP1 cDNA corresponding to clone NM_003146
was cloned into the pcDNA5 FRT/TO vector (Invitrogen™), modified with an N-
terminal Flag-TAG (gift from Zuzana Horejesi, Clare Hall Laboratories). DNA
encoding full length Flag-SSRP1 1-709aa, Flag-SSRP1NTD 1-180aa, Flag-
SSRP1ΔHMG 1-508aa, and Flag-SSRP1ΔNTD 529-709aa were amplified by PCR
using primers listed below. The Flag-SSRP1R213D and Flag-SSRP1ΔHMG were
generated by site-directed mutagenesis with the QuikChange strategy (Stratagene)
according to the manufacturer’s protocol. The DNA fragments obtained were
inserted into the pGEX-4T-3 vector (GE, 28-9545-52). This vector encodes an
Glutathion-S-Transferase (GST)-tag followed by a Thrombin protease cleavage site.
Primers to clone hSSRP1 cDNA into pcDNA5FRT/TO modified with N-
terminal Flag-TAG
hSSRP1-attB1-Fwd
5′GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGGCAGAGACAC
TGGAGTTCAACGACG-3′
hSSRP1-attB2-Rev
5′GGGGACCACTTTGTACAAGAAAGCTGGGTCCTACTACTCATCGGAT
CCTGACGCTGAGTCC3′
Primers to clone hSSRP1 and its mutated versions into pGEX-4T-3 vector
hSSRP1-Full length-Fwd
5′-TTTTCCCGGGACCGGTTTATGGACTACAAGGACGACGATG- 3′
hPmeI-Full length-Rev
5′-TTTTGCGGCCGCGTTTAAACACCACTTTGTACAAGAAAGCTGGG- 3′
NTD-Rev
5′-TTTTGCGGCCGCGTTTAAACGGCCTCAACAGGGTCCACAC- 3′
ΔNTD-Fwd
5′-TTTTGACTCCATGGTTTGCCCAGAATGTGTTGTCAAAGGC- 3′
Preparation of recombinant proteins. Glutathion-S-Transferase (GST)-Flag-
tagged human SSRP1 protein was expressed in Rosetta™(DE3)pLysS Competent
Cells (Novagen, 70956) and purified on Glutathione Sepharose™ 4 Fast Flow (GE,
17513201). Briefly, E. coli were grown in LB media containing ampicillin at 37 °C
until reaching an OD of 0.6–1.0 at 600 nm. Then cultures were shifted to 25 °C and
induced with 0.2 mM isopropyl-β-D-thiogalactopyranoside (IPTG) for 3 h. Cells
were collected by centrifugation at 4000 × g for 20 min at 4 °C and pellets were
suspended in lysis buffer (300 mM NaCl, 200 mM HEPES pH 7.5, 1% Triton-X100,
1 mM DTT) supplemented with protease inhibitor cocktail (Millipore). Cells were
then disrupted by sonication and incubated 10 min at 4 °C with 25 µg/ml DNase I.
Lysate was clarified by centrifugation at 21,000 × g for 45 min at 4 °C and incubated
with 2 ml of Glutathione beads (GE) in rotation for 1 h at 4 °C. Beads were applied
on a gravity column and washed twice with 20 volumes of lysis buffer. The proteins
were eluted with elution buffer (150 mM NaCl, 20 mM HEPES pH 7.5, 1 mM DTT
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and 20 mM Glutathione pH 8.0) and dyalized. SSRP1 proteins were cleaved from
the GST fusion using the appropriate protease, and further purified by SEC on
Superdex-200 column (GE Healthcare) pre-equilibrated in SEC buffer (50 mM
HEPES, 150 mM NaCl, 10% glycerol). Relevant fractions were concentrated in
50 kDa molecular mass cut-off Amicon ultra centrifugal filters (Millipore). Human
Spt16 protein was a kind gift from P. Cherepanov (Imperial College, London,
England).
Immunoprecipitation assays. Mouse monoclonal anti-SSRP1 antibodies (clone
10D7; abcam) (4 µg) were incubated with 35 µl slurry of Protein A Sepharose®
4 FastFlow (GE Healthcare) for 2 h on a rotating wheel at 4 °C with 1 µg recom-
binant histone H1.0 (New England Biolabs, M2501S), 5 µg Flag-SSRP1 or Spt16
and Flag-SSRP1 (5 µg each). Beads were washed four times with washing buffer
(10 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA pH 8.0, 1%
Triton X-100, 0.2 mM sodium orthovanadate) supplemented with protease inhi-
bitors cocktail. Samples were eluted by heating Laemmli buffer without β-
mercaptoethanol for 10 min at 37 °C. Eluted samples were boiled for 5 min, loaded
on a SDS-PAGE gel and transfer to nitrocellulose membrane for western blot
analysis.
For the in vitro interaction, 1 µg of recombinant histone H1.0 was either
incubated with 5 µg of Flag-SSRP1, Flag-SSRP1 mutants or Spt16 and Flag-SSRP1
(5 µg each) in the FLAG-IP buffer (50 mM Tris-HCl pH 7.4, 200 mM NaCl, 1 mM
EDTA, 1% Triton X-100) supplemented with fresh protease inhibitors (Millipore)
for 2 h on a rotating wheel at 4 °C. FLAG-IP was carried out using anti-FLAG M2
affinity gel (Sigma, A2220). For a single reaction, 40 µl gel suspension was washed
twice with FLAG-IP buffer and was incubated with recombinant proteins for 1 h at
4 °C. Protein-bound beads were then washed four times in the same buffer and
proteins were eluted by boiling in Laemmli buffer and subjected to immunoblot
analysis.
Xenopus laevis embryos and microinjections. X. laevis embryos were obtained by
in vitro fertilization of freshly laid X. laevis eggs with crushed X. laevis testes. Only
batches with greater than 90% fertilization efficiency were used. 20 min after fer-
tilization, embryos were de-jellied in 2% Cysteine pH 8.1 dissolved in 0.1 ×MBS
(88 mM NaCl, 1 mM KCl, 0.4 CaCl2, 0.33 mM Ca[NO3]2, 0.8 mM MgSO4, 5 mM
TRIS-HCl, 2.4 mM NaHCO3). Microinjections were performed using calibrated
needles and embryos equilibrated in 1xMBS/3% Ficoll PM-400 (Sigma). Micro-
injection needles were generated from borosilicate glass capillaries (Harvard
Apparatus, GC 100F-15) using the micropipette puller Sutter p97. Approximately
4 nl mRNA were injected into de-jellied embryos at the 1-cell stage using the
microinjector PicoSpritzer III (Parker). After the first cleavage, the buffer was
replaced with 1 ×MBS/2% Ficoll then 0.1×MBS and embryos were allowed to
develop to the desired stage. Embryos were staged according to Nieuwkoop and
Faber, 1975. Histone H1.0 cDNA corresponding to human transcript
NM_0005318.3 cloned into pET28a(+) vector was obtained from GenScript
(OHu16206c). For in vitro transcription, the fragments were cloned between the
FseI and AscI sites of pCS2 vector (pCS2-6xMYC_SSRP1, pCS2-
6xMYC_SSRP1ΔNTD, pCS2-6xMYC_SSRP1NTD, pCS2-6xMYC_H1.0). To
obtain sense RNA from these constructs, plasmids were linearized with NotI;
pCS2-6xMYC_H1.0 plasmid was linearized with MfeI. Following linearization,
mRNA was expressed from the SP6 promoter using the mMessage mMachine kit
(Ambion). All constructs were verified by DNA sequencing. The pCS2 vector was a
gift from Philip Zegerman (The Gurdon Institute, University of Cambridge).
Primers for cloning into pCS2 vector:
SSRP1_FseI_Fwd 5′-ATTTTAAAGGCCGGCCAATGGCAGAGACACTG
GA- 3′
ΔNTD_FseI_Fwd 5′-ATTTTAAAGGCCGGCCAATGGCATTTGCCCAGA
ATGTG- 3′
SSRP1_AscI_Rev 5′-TAAAAGGGGGCGCGCCCTACTCATCGGATCCTG- 3′
NTD_AscI_Rev 5′-TAAAAGGGGGCGCGCGTTTAAACGGCCTCAACAGG
GTCC - 3′
H1.0_FseI_Fwd 5′-ATTTTGGGGGCCGGCCAATGACCGAGAATTCCA
CGTCCG- 3′
H1.0_AscI_Fwd 5′-TAAAAGGGGGCGCGCCTTACTTCTTCTTGCCGG
CCC- 3′
Xenopus embryos protein analysis. Embryos were lysed in 50 µl/embryo lysis
buffer (50 mM Tris pH 7.6, 150 mM NaCl,10 mM EDTA, 1% TritonX-100) sup-
plemented with protease inhibitors, incubated on ice for 30 min, sonicated for
15 min on High setting 30 s ON/OFF and centrifuged at high speed for 10 min at
4 °C. Protein concentration was determined using Biorad protein assay according
to the manufacturer’s instructions (Biorad Laboratories).
Antibodies and western blot analysis. Samples were resolved by 4–15% SDS-
PAGE and analyzed by standard WB techniques. Blots were probed using the
following custom antibodies at dilutions indicated in parenthesis: rabbit polyclonal
anti-Xenopus Cdc45 (1:2000), mouse monoclonal anti-Xenopus Orc1 (1:100,000)
previously described45,46; rabbit polyclonal anti-Xenopus Orc2 (1:4000), mouse
monoclonal anti-Cdk1 (A17, 1:500), mouse monoclonal anti-Cdk1 pTyr15
(1:1000), mouse monoclonal anti-Xenopus Cyclin B2 (X121, 1:500) antibodies
obtained from J. Gannon, The Francis Crick Institute, London, UK and rabbit
polyclonal anti-Xenopus H2A.X-F (1:10,000), obtained by D. Shechter, A. Einstein
Institute, New York, NY, USA. The following commercial antibodies were also
used: mouse monoclonal anti-MCM7 (47DC141, Santa Cruz Biotechnology, sc-
9966, 1:4000), anti-PCNA (PC10, Serotec, MCA1558, 1:5000), mouse monoclonal
anti-Cdt1 (F-6, Santa Cruz Biotechnology, sc-365305, 1:500), mouse monoclonal
anti-Ssrp1 (10D7, Abcam, ab26212, 1:1000), rabbit polyclonal anti-Ssrp1 (A303-
068A, Bethyl Laboratories, 1:1000), rabbit polyclonal anti-Spt16 (H-300, Santa
Cruz Biotechnology, sc-28734, 1:250), rabbit polyclonal anti-Cdc6 (Santa Cruz
Biotechnology, sc-8341, 1:1000), mouse monoclonal anti-Xenopus Polα (p180)
(Abmart, clone 13026-1-3/C199, 1:500), mouse monoclonal anti-H1.0 (Abcam,
ab11079, 1:1000), rabbit polyclonal anti-H2B (Millipore, 07-371, 1:1000), mouse
monoclonal anti-FLAG-M2-Peroxidase-HRP (A8592, Sigma, 1:1000) and rabbit
polyclonal anti-SMC2 (Bethyl, A300-056A, 1:1000). Detection with secondary
antibodies was commonly carried out at 1:10,000. Proteins were detected by ECL
detection reagents (GE) or WesternBright ECL (Advansta) on Amersham
Hyperfilm (GE) or Kodak.
Immunohistochemistry on Xenopus embryos. Embryos at the indicated devel-
opmental stage were fixed in 4% paraformaldehyde (PFA) overnight at 4 °C. Where
indicated tadpoles were irradiated with 5 Gys with Faxitron before fixation. After
fixation, embryos were embedded in 1% LMP agarose and then in paraffin with
Diapath automatic processor (Diapath). To assess histological features hematox-
ylin/eosin staining (Diapath) was performed according to standard protocol and
samples were mounted in Eukitt (Bio-Optica). For IHC analysis, paraffin was
removed with xylene and the sections were re-hydrated in graded alcohol. Antigen
retrieval was carried out using pre-heated target retrieval solution for 45 min.
Tissue sections were stained with 0.3% H2O2 for 10 min at room temperature for
quenching of endogenous peroxide activity, and then blocked with 0.2% Fetal
Bovine Serum (FBS) in PBS supplemented with 1% BSA for 1 h and incubated for
2 h with primary antibodies. Mouse monoclonal anti-phospho-histone H2A.X
(Ser139) (JBW301, Millipore, 1:500) was used for staining. Antibody binding was
detected using a polymer detection kit (GAR-HRP and GAM-HRP, Microtech),
followed by a diaminobenzidine chromogen reaction (Peroxidase substrate kit,
DAB, SK-4100; Vector Lab). All sections were counterstained with Mayer's
hematoxylin and visualized using a bright-field microscope.
DNA quantification in Xenopus embryos. For each condition, four embryos were
homogenized in 500 μl DNA extraction buffer (10 mM Tris pH 8.0, 0.2 mM EDTA,
0.5% SDS) supplemented with 100 μg/ml proteinase K and incubated at 55 °C
overnight. Samples were extracted twice in one volume of phenol:chloroform:iso-
amyl alcohol (25:24:1) and once with chloroform. Genomic DNA was ethanol
precipitated and resuspended in 15 μl H2O. Samples were incubated with 50 μg/ml
RNase A and incubated at 37 °C for 2 h. Genomic DNA was run on 1% TAE
agarose gel and visualized by staining with ethidium bromide. DNA was quantified
using Quantity One software (BioRad) or ImageJ.
Imaging and measurement of embryos and tadpoles. Tailbud stages were
imaged using a Nikon SMZ1500 stereomicroscope coupled to a Nikon DS-Fi1-U2
color camera at ×0.75 magnification with fiber optic illumination using NIS-
Elements software. Tadpoles were imaged by placing them in a petri dish filled with
water. Images were analysed and length measured head to tail. Length measure-
ments were taken using the line tool in ImageJ.
Embryo movies were acquired with a time-frame of 3 min covering an overall
period of 8 h of development, and then displayed at a rate of seven frames
per second (fps).
Cell cycle duration measurement. Images were captured every 3 min on an
Olympus SZX16 stereomicroscope equipped with a Leica DFC450C color camera
at ×0.7 magnification with fiber optic illumination using MetaMorph7.8 software.
Time-lapse movies of injected embryos were played and divisions were counted to
determine the frame number of the forth cleavage. The inter-cleavage period was
determined by tracking individual cells and noting the frame number at which the
cleavage furrow visibly transected the entire cell. When daughter cells did not
divide concurrently, the division time of the earliest dividing daughter was used,
and that cell was followed for the remaining time of the movie. When the cleavage
could not be observed, as in cases where the cleavage plane did not intersect with
the embryo surface, the cell was omitted from analysis.
Quantitative real-time PCR (qRT-PCR). For each condition, four embryos were
lysated using TRIzol reagent (Invitrogen), then total RNA was extracted using
Direct-zol™ DNA/RNA MiniPrep kit (Zymo Research). First-Strand cDNA
synthesis was performed with the iScript™ Advanced cDNA Synthesis Kit (BioRad).
qPCR was performed using SsoFast EvaGreen Supermixes (BioRad) and a Roche
LightCycler 96. All reactions were performed in triplicate, at a minimum. The
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following program was used: 95 °C for 600 s; 45 cycles of 95 °C for 10 s, 60 °C for
30 s; increasing at 0.2 °C/s from 65 °C to 97 °C. Gene expression was normalized to
H4 and calculated by the DDCt method. Primer sequences are provided here:
BMP4-Fwd 5′- TCCTGCTCGGAGGCACTAAC -3′,
BMP4-Rev 5′-ACTTTCTTCTTGCCCGTGTCA-3′,
MyoD-Fwd 5′- CAACCAAAGGCTCCCCAAA-3,
MyoD_Rev 5′-GAGGCTCTCTATGTAGCGAATCG -3′,
xVent1-Fwd 5′- CCCAACAAATAAGCAAACTGGAA -3′,
xVent1-Rev 5′- CAGGTGCCCCCAGATATCTC -3′,
xVent2-For 5′- CCAGAACCGCAGGATGAAAT -3′;
xVent2-Rev 5′- GGTATGAGTCTGGTCTGCCATCT -3′,
Gsc-Fwd 5′- AGGCACAGGACCATCTTCACCG -3′,
Gsc-Rev 5′- CACTTTTAACCTCTTCGTCCGC -3′,
Mix1-Fwd 5′- TCAGCCATTTGCCATGAATC -3′,
Mix1-Rev 5′- TGGGATGCTGCTGGAAGTC -3′,
H4-Fwd 5′- AGGGACAACATCCAGGGCATCACC -3′,
H4-Rev 5′- ATCCATGGCGGTAACGGTCTTCCT -3′
Quantification and statistical analysis. Statistical analysis (Student’s t-test, two-
tailed) and analysis of variation (ANOVA) were performed with GraphPad Prism
7 software and indicated in figure legends. Images shown represent typical results.
All experiments have been repeated at least three times.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data supporting the findings of this manuscript have all been included. A separate source
data file contains raw data underlying Figs. 1a, b, d, e, 2a–g, 3a–d, 4a, c, 5a–f, 6b, c, e, f, h,
i, 7b, c, e, f, h, i and Supplementary Figs. 2a, c, e, 3a, b, 4, 5a, c, 6, 7 and 8c–e. A reporting
summary for this article is available as a Supplementary Information file linked to this
manuscript. Proteomics data have been deposited to the ProteomeXchange Consortium
via PRIDE with the dataset identifier PXD017383.
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